The data suggest that the described Exiqon profiling was uniformly unsuccessful for the mainstay SH-SY5Y experiments and for several of the fetal neuron samples. Only 12 confirmed miRNAs were detected above background plus two standard deviations in all conditions of the SH-SY5Y experiment. It is unclear how reliable, quantile normalized data could be generated from background-level signal, but the processed values as provided also show no consistent changes of reported miRNAs for SH-SY5Y or fetal neurons.
Given the quality of the Exiqon data, especially for the cell line experiments advanced as the primary support, the authors are commended for providing additional, unpublished Agilent and Affymetrix data.
However, the "quantile normalized" Agilent data are unnormalized raw values. Distributions of the "processed" Affymetrix data appear similarly inconsistent with normalization. MIAME compliance aside, data across the various platforms and cell types seem to challenge, e.g. the reported quantitative PCR finding of Tat-mediated, Ͼ400-fold miR-34a up-regulation. Experimental and analytical replication is needed, guided by an indication of which arrays contributed to Fig. 3 
